AMO's IOL to be reimbursed in US

Following designation of New Technology Intraocular Lens (NTIOL) status by the Centers for Medicare and Medicaid Services (CMS), AMO has introduced the Tecnis 1-Piece IOL to the US market.

Related Content:

ArticlesCataract & Refractive

Opportunities lie ahead at the 39th ‘hybrid’ ESCRS

Ultra-widefield imaging improves visibility of retina and optic nerve in KPro patients

Cataract surgeons on operating theatre waste: Less is often more